Assess Bronchodilator Effect and Safety of Two Doses of QVM149 Compared to a Fixed Dose Combination of Salmeterol/Fluticasone in Patients With Asthma.
Clinical trial NCT03063086 · COMPLETED
Trial details
- NCT number
- NCT03063086
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-21
- Primary completion
- 2018-08-02
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.